Read our latest news

We have achieved full recruitment for our ongoing iBox clinical trial: more than 500 patients were recruited! This study aims to demonstrate

Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure

Predict4Health has garnered a substantial user base worldwide, positively impacting patient care.

We have announced that the first patient in the UK has been enrolled to the iBox clinical trial !

We, as a start-up specializing in predictive medicine devices, has obtained Class IIa CE marking for its Apilife solution

This marks the beginning of this first-of-its-kind clinical trial conducted in Europe evaluating a digital health solution.

The CE marking allows the company to market its medical device in all countries that recognize this certification...